Potential roles of ROR-α in cardiovascular endocrinology
Nuclear Receptor Signaling · 2003
DOI: 10.1621/nrs.01011 ↗At a glance
Journal article in Nuclear Receptor Signaling, 2003. Written by Saara Laitinen and 1 co-authors. Institution: UR545 INSERM, Institut Pasteur de Lille, and Faculte de Pharmacie, Universite de Lille II, 1 rue du Pr Calmette 59019 Lille, France. Cited 7 times so far (Crossref); 29 references. The full text is freely available in PubMed Central.
Abstract (original language)
Atherosclerosis is a chronic disease of the arteries whose development involves a local inflammatory response characterized by the activation of different cells such as macrophages, T-lymphocytes, smooth muscle cells (SMCs) and endothelial cells (ECs). This review will summarize recent evidence for a modulatory role of the nuclear receptor ROR-alpha in cardiovascular disease.
Authors and institutions
- UR545 INSERM, Institut Pasteur de Lille, and Faculte de Pharmacie, Universite de Lille II, 1 rue du Pr Calmette 59019 Lille, France.
Cite
APA
Laitinen, S., & Staels, B. (2003). Potential roles of ROR-α in cardiovascular endocrinology. Nuclear Receptor Signaling. https://doi.org/10.1621/nrs.01011
Vancouver
Laitinen S, Staels B. Potential roles of ROR-α in cardiovascular endocrinology. Nuclear Receptor Signaling. 2003. doi:10.1621/nrs.01011
BibTeX
@article{Laitinen2003,
author = {Laitinen, Saara and Staels, Bart},
title = {Potential roles of ROR-α in cardiovascular endocrinology},
journal = {Nuclear Receptor Signaling},
year = {2003},
doi = {10.1621/nrs.01011}
}
EUVIMED